BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23207686)

  • 1. TROP2 correlates with microvessel density and poor prognosis in hilar cholangiocarcinoma.
    Ning S; Guo S; Xie J; Xu Y; Lu X; Chen Y
    J Gastrointest Surg; 2013 Feb; 17(2):360-8. PubMed ID: 23207686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of trophoblast cell surface antigen 2 enhances proliferation and migration in liver fluke-associated cholangiocarcinoma.
    Sawanyawisuth K; Tantapotinan N; Wongkham C; Riggins GJ; Kraiklang R; Wongkham S; Puapairoj A
    Ann Hepatol; 2016; 15(1):71-81. PubMed ID: 26626643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-associated lymphangiogenesis correlates with lymph node metastases and prognosis in hilar cholangiocarcinoma.
    Thelen A; Scholz A; Benckert C; Weichert W; Dietz E; Wiedenmann B; Neuhaus P; Jonas S
    Ann Surg Oncol; 2008 Mar; 15(3):791-9. PubMed ID: 18172731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microvessel density correlates with lymph node metastases and prognosis in hilar cholangiocarcinoma.
    Thelen A; Scholz A; Benckert C; Schröder M; Weichert W; Wiedenmann B; Neuhaus P; Jonas S
    J Gastroenterol; 2008; 43(12):959-66. PubMed ID: 19107340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors).
    Schmitz KJ; Lang H; Kaiser G; Wohlschlaeger J; Sotiropoulos GC; Baba HA; Jasani B; Schmid KW
    Hum Pathol; 2009 Dec; 40(12):1706-14. PubMed ID: 19683330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-8 is a prognostic indicator in human hilar cholangiocarcinoma.
    Sun Q; Li F; Sun F; Niu J
    Int J Clin Exp Pathol; 2015; 8(7):8376-84. PubMed ID: 26339407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.
    Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J
    World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prognostic Impact of Leucine-Rich α-2-Glycoprotein-1 in Cholangiocarcinoma and Its Association With the IL-6/TGF-β1 Axis.
    Jin Z; Kobayashi S; Gotoh K; Takahashi T; Eguchi H; Naka T; Mori M; Doki Y
    J Surg Res; 2020 Aug; 252():147-155. PubMed ID: 32278969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with otherwise node-negative hilar cholangiocarcinoma.
    Tojima Y; Nagino M; Ebata T; Uesaka K; Kamiya J; Nimura Y
    Ann Surg; 2003 Feb; 237(2):201-7. PubMed ID: 12560778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of tumor microvessels in intrahepatic cholangiocarcinoma: association with tumor-infiltrating lymphocytes.
    Yugawa K; Itoh S; Yoshizumi T; Iseda N; Tomiyama T; Toshima T; Harada N; Kohashi K; Oda Y; Mori M
    Mod Pathol; 2021 Apr; 34(4):798-807. PubMed ID: 33077921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biopathological characteristics of hilar cholangiocarcinoma and the clinical significance].
    Yu WL; Zhang YJ; Dong H; Yu H; Xian ZH; Wu MC; Cong WM
    Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(15):1162-6. PubMed ID: 20021908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ratio of MMP-2 to TIMP-2 in hilar cholangiocarcinoma: a semi-quantitative study.
    Xiao M; Zhou NX; Huang ZQ; Lu YL; Chen LH; Wang DJ; Chang WL
    Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):599-602. PubMed ID: 15567754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annexin-1 downregulation is associated with clinical outcome in Chinese patients with hilar cholangiocarcinoma.
    Wang D; Zhang H; Fang Z; Yu G
    Eur Surg Res; 2010; 45(3-4):151-7. PubMed ID: 20924191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
    Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
    Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of TROP2 correlates with poor prognosis in pancreatic cancer.
    Fong D; Moser P; Krammel C; Gostner JM; Margreiter R; Mitterer M; Gastl G; Spizzo G
    Br J Cancer; 2008 Oct; 99(8):1290-5. PubMed ID: 18813308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased intratumoral arteries reflect portal tract destruction and aggressive characteristics in intrahepatic cholangiocarcinoma.
    Aishima S; Iguchi T; Nishihara Y; Fujita N; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M
    Histopathology; 2009 Mar; 54(4):452-61. PubMed ID: 19309397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of specialized multi-disciplinary approach and an integrated pathway on outcomes in hilar cholangiocarcinoma.
    Gomez D; Patel PB; Lacasia-Purroy C; Byrne C; Sturgess RP; Palmer D; Fenwick S; Poston GJ; Malik HZ
    Eur J Surg Oncol; 2014 Jan; 40(1):77-84. PubMed ID: 24262111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An analysis on prognostic factors of hilar cholangiocarcinoma].
    Zhou LX; Zhang ZW; Xu ZY
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1275-7. PubMed ID: 19595185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical procedure and prognosis of hilar cholangiocarcinoma.
    Yi B; Zhang BH; Zhang YJ; Jiang XQ; Zhang BH; Yu WL; Chen QB; Wu MC
    Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):453-7. PubMed ID: 15313688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.